If you liked this article you might like

Tesaro Secures Early and Broad Approval for PARP Inhibitor in Ovarian Cancer
XBiotech Silent as Deadline for European Resubmission of Colon Cancer Drug Passes
Alexion Pharma, Still Recovering From Boardroom Troubles, Appoints New CEO
Biotech Stock Mailbag: Sage Therapeutics, Cellceutix, Alzheimer's Risk